LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PRE...
LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study
Buyer
University of Leicester
Value
£1,057,433
Published
14 Oct 2021
Closes
12 Oct 2021
Procurement details
Source
Contracts Finder
Region
Leicester
Procurement method
Open
Category
Services
Contract starts
13 Oct 2021
Contract ends
31 May 2031
CPV classifications
73000000
Research and development services and related consultancy services
Lots
Lot default LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resve...
£1,057,433
LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
14 Oct 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Please follow this link to view the notice.
Not provided
Please follow this link to view the notice.
Tender notice
Contains public sector information licensed under the Open Government Licence v3.0.